Kisspeptin Variations in Patients with Polycystic Ovary Syndrome—A Prospective Case Control Study
<i>Background and objectives</i>: Kisspeptin, also named metastin, showed important roles in initiating the secretion of gonadotropin-releasing hormone (GnRH) and is an essential factor in the development of polycystic ovaries syndrome (PCOS). Several research studies noticed association...
Main Authors: | Mona Akad, Răzvan Socolov, Cristina Furnică, Roxana Covali, Catalina Daniela Stan, Eduard Crauciuc, Ioana Pavaleanu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/58/6/776 |
Similar Items
-
Prenatal kisspeptin antagonist exposure prevents polycystic ovary syndrome development in prenatally-androgenized rats in adulthood: An experimental study
by: Elahe Sadeghian Bakhi, et al.
Published: (2023-02-01) -
Treatment of polycystic ovary syndrome in rats by kisspeptin
by: Zainab Alaulddin M. Hussien, et al.
Published: (2020-06-01) -
Effect of Hypoglycemic Drugs on Kisspeptin Expression in the Hypothalamic Arcuate Nucleus of PCOS Rats
by: Zheng P, et al.
Published: (2023-09-01) -
Kisspeptin regulates the proliferation and apoptosis of ovary granulosa cells in polycystic ovary syndrome by modulating the PI3K/AKT/ERK signalling pathway
by: Pingping Sun, et al.
Published: (2023-01-01) -
Epidemiology of polycystic ovary syndrome, endometriosis and their comorbid course
by: А.S. Khmil Doswald, et al.
Published: (2022-02-01)